HealthStream Announces Second Quarter 2015 Results
Highlights:
-
CEO contributed
$1.65 million of his personally heldHealthStream stock to the Company in order to facilitate stock grants to over 600 employees, which resulted in a charge of$1.65 million for compensation and related expense in the second quarter -
Revenues of
$52.1 million in the second quarter of 2015, up 23% from$42.5 million in the second quarter of 2014 -
Operating income of
$2.6 million in the second quarter of 2015, down 38% from$4.1 million in the second quarter of 2014, which was adversely impacted by the$1.65 million charge associated with the stock grant to employees referenced above and a$2.7 million reduction resulting from the deferred revenue write-down associated with the HealthLine Systems and HCCS acquisitions -
Net income of
$1.5 million in the second quarter of 2015, down 38% from$2.4 million in the second quarter of 2014, and earnings per share (EPS) of$0.05 per share (diluted) in the second quarter of 2015, compared to$0.08 per share (diluted) in the second quarter of 2014 -
Adjusted EBITDA1 of
$8.8 million in the second quarter of 2015, up 21% from$7.3 million in the second quarter of 2014 -
Approximately
$98 million raised in follow-on public offering of approximately 3.9 million shares ofHealthStream common stock
Financial Results:
Second Quarter 2015 Compared to Second Quarter 2014
Revenues for the second quarter of 2015 increased by
Revenues from our HealthStream Workforce Solutions segment increased by
Revenues from our HealthStream Patient Experience Solutions segment
increased by
Revenues from our HealthStream Provider Solutions segment increased by
Generally accepted accounting principles (GAAP) require companies to
write down beginning balances of acquired deferred revenue balances as
part of "fair value" accounting as defined by GAAP. During the second
quarter of 2015,
Operating income was
Net income was
Adjusted EBITDA (which we define as net income before interest, income
taxes, share-based compensation, and depreciation and amortization)
increased by 21 percent to
At
Year-to-Date 2015 Compared to Year-to-Date 2014
For the first six months of 2015, revenues were
Other Business Updates
At
Annualized revenue per implemented subscriber for Workforce Solutions
We view the metric, "Annualized Revenue per Implemented Subscriber for our Workforce Solutions" ("Workforce ARIS"), as one of several insightful measures of our progress in growing the value of our customer base. Workforce ARIS represents the quarter's revenue from our subscription-based solutions, annualized, then divided by the quarter's average total number of implemented subscribers. Our subscription-based solutions include subscriptions to our platform applications, plus courseware/content subscriptions.
For the second quarter of 2015, HealthStream's Workforce ARIS was
Follow-on Public Offering of HealthStream Common Stock
On
Financial Outlook for 2015
For 2015, we anticipate that consolidated revenues will grow 18 to 21
percent as compared to 2014. We anticipate that revenue growth in our
Workforce Solutions segment will be in the 15 to 18 percent range and
approximately one to three percent in our Patient Experience Solutions
segment. We anticipate our Provider Solutions segment's revenue to
contribute between
We anticipate that the Company's 2015 full-year operating income will decrease between 25 and 35 percent as compared to full-year 2014 results. This operating income range takes into account the following:
-
Between
$6.5 million and$7.5 million of write-down to the deferred revenue balances of HLS; -
Approximately
$1 million of transaction costs related to the HLS acquisition incurred in the first quarter of this year; - An increased rate of investment over full-year 2014 in HealthStream's product development related to new products, enhancements to existing products, and integration of acquired products—including an increase in investment in HLS's products;
-
An increase in expense related to sales and marketing investments,
including the Company's customer Summit, which was held in
Nashville during the second quarter of 2015; and -
Share-based compensation and related expenses of
$1.65 million associated with stock awarded to employees through the special contribution to the Company of personally held shares by HealthStream's CEO.
We anticipate that our full-year 2015 capital expenditures will be
between
The aforementioned guidance does not include the impact from any other acquisitions that we may complete during 2015.
Commenting on second quarter 2015 results,
A conference call with
Use of Non-GAAP Financial Measures
This press release contains certain non-GAAP financial measures, including non-GAAP net income, non-GAAP operating income, non-GAAP revenue, and adjusted EBITDA, which are used by management in analyzing the Company's financial results and ongoing operational performance.
In order to better assess the Company's financial results, management believes that income before interest, income taxes, share-based compensation, depreciation and amortization ("adjusted EBITDA") is a useful measure for evaluating the operating performance of the Company because adjusted EBITDA reflects net income adjusted for non-cash and non-operating items. Adjusted EBITDA is also used by many investors to assess the Company's results from current operations. Adjusted EBITDA is a non-GAAP financial measure and should not be considered as a measure of financial performance under GAAP. Because adjusted EBITDA is not a measurement determined in accordance with GAAP, it is susceptible to varying calculations. Accordingly, adjusted EBITDA, as presented, may not be comparable to other similarly titled measures of other companies.
Over the past few years, the Company has acquired businesses whose net tangible assets include deferred revenue. In accordance with GAAP reporting requirements, the Company may record a write down of deferred revenue to fair value as defined in GAAP. If the Company is required to record a write-down of deferred revenue, it may result in lower recognized revenue, operating income, and net income. In order to provide more accurate trends and comparisons of the Company's revenues, operating income, and net income, management believes that adding back the deferred revenue write-down associated with fair value accounting for acquired businesses provides a useful measure of the ongoing performance of the Company. Both on a quarterly and year-to-date basis, the revenue for the acquired business is deferred and typically recognized over a one to two year period following the completion of any particular acquisition, so our GAAP revenues for this one to two year period will not reflect the full amount of revenues that would have been reported if the acquired deferred revenue was not written down to fair value.
These non-GAAP financial measures should not be considered as a substitute for, or superior to, measures of financial performance which are prepared in accordance with GAAP and may be different from non-GAAP financial measures used by other companies. Investors are encouraged to review the reconciliations of our GAAP to non-GAAP financial measures, which are set forth below in this release.
About
1 Adjusted EBITDA is a non-GAAP financial measure. A reconciliation of adjusted EBITDA to net income is included in this release.
|
||||||||||||||||
Condensed Consolidated Statements of Income | ||||||||||||||||
(In thousands, except per share data) | ||||||||||||||||
Unaudited | ||||||||||||||||
Three Months Ended
|
Six Months Ended
|
|||||||||||||||
2015 |
2014 |
2015 |
2014 |
|||||||||||||
Revenues | $ | 52,145 | $ | 42,476 | $ | 99,301 | $ | 80,825 | ||||||||
Operating expenses: | ||||||||||||||||
Cost of revenues (excluding depreciation and amortization) |
22,432 |
18,738 |
42,625 |
35,663 |
||||||||||||
Product development | 5,815 | 4,294 | 10,460 | 7,840 | ||||||||||||
Sales and marketing | 10,328 | 7,251 | 17,675 | 14,199 | ||||||||||||
Other general and administrative | 6,750 | 5,361 | 13,678 | 10,592 | ||||||||||||
Depreciation and amortization | 4,256 | 2,722 | 7,509 | 5,123 | ||||||||||||
Total operating expenses |
49,581 | 38,366 | 91,947 | 73,417 | ||||||||||||
Operating income | 2,564 | 4,110 | 7,354 | 7,408 | ||||||||||||
Other income (expense), net | (44 | ) | 23 | (35 | ) | 68 | ||||||||||
Income before income taxes | 2,520 | 4,133 | 7,319 | 7,476 | ||||||||||||
Income tax provision | 1,047 | 1,769 | 3,124 | 3,165 | ||||||||||||
Net income | $ | 1,473 | $ | 2,364 | $ | 4,195 | $ | 4,311 | ||||||||
Net income per share: | ||||||||||||||||
Net income per share, basic | $ | 0.05 | $ | 0.09 | $ | 0.15 | $ | 0.16 | ||||||||
Net income per share, diluted | $ | 0.05 | $ | 0.08 | $ | 0.15 | $ | 0.15 | ||||||||
Weighted average shares outstanding: | ||||||||||||||||
Basic | 29,234 | 27,567 | 28,469 | 27,510 | ||||||||||||
Diluted | 29,617 | 28,043 | 28,843 | 27,975 | ||||||||||||
|
|||||||||
Condensed Consolidated Balance Sheets | |||||||||
(In thousands) | |||||||||
Unaudited | |||||||||
|
|
||||||||
2015 |
2014(1) |
||||||||
ASSETS | |||||||||
Current assets: | |||||||||
Cash and cash equivalents | $ | 54,493 | $ | 81,995 | |||||
Marketable securities | 85,408 | 38,973 | |||||||
Accounts and unbilled receivables, net | 34,917 | 34,845 | |||||||
Prepaid and other current assets | 24,050 | 18,798 | |||||||
Total current assets | 198,868 | 174,611 | |||||||
Capitalized software development, net | 13,634 | 12,706 | |||||||
Property and equipment, net | 11,282 | 9,442 | |||||||
Goodwill and intangible assets, net | 143,593 | 56,709 | |||||||
Other assets | 3,973 | 3,794 | |||||||
Total assets | $ | 371,350 | $ | 257,262 | |||||
LIABILITIES AND SHAREHOLDERS' EQUITY | |||||||||
Current liabilities: | |||||||||
Accounts payable, accrued and other liabilities | $ | 22,018 | $ | 23,543 | |||||
Deferred revenue | 64,945 | 53,716 | |||||||
Total current liabilities | 86,963 | 77,259 | |||||||
Deferred tax liabilities, non-current | 5,654 | 5,838 | |||||||
Deferred revenue, noncurrent | 4,232 | 3,657 | |||||||
Other long-term liabilities | 2,598 | 2,649 | |||||||
Total liabilities | 99,447 | 89,403 | |||||||
Shareholders' equity: | |||||||||
Common stock | 274,816 | 174,926 | |||||||
Comprehensive loss | (78 | ) | (37 | ) | |||||
Accumulated deficit | (2,835 | ) | (7,030 | ) | |||||
Total shareholders' equity | 271,903 | 167,859 | |||||||
Total liabilities and shareholders' equity | $ | 371,350 | $ | 257,262 | |||||
(1) |
Derived from audited financial statements contained in the
Company's filing on Form 10-K for the year ended |
||||||||
|
||||||||
Condensed Consolidated Statements of Cash Flows | ||||||||
(In thousands) | ||||||||
Unaudited | ||||||||
Six Months Ended | ||||||||
|
|
|||||||
2015 |
2014 |
|||||||
Operating activities: | ||||||||
Net income | $ | 4,195 | $ | 4,311 | ||||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||
Depreciation and amortization | 7,509 | 5,123 | ||||||
Deferred income taxes | 823 | 3,165 | ||||||
Share-based compensation | 2,347 | 834 | ||||||
Provision for doubtful accounts | 119 | 70 | ||||||
Other | 386 | 752 | ||||||
Changes in assets and liabilities: | ||||||||
Accounts and unbilled receivables | 3,055 | (3,558 | ) | |||||
Prepaid and other assets | (2,182 | ) | (4,493 | ) | ||||
Accounts payable, accrued and other liabilities | (2,834 | ) | 1,209 | |||||
Deferred revenue | 5,713 | 14,689 | ||||||
Net cash provided by operating activities | 19,131 | 22,102 | ||||||
Investing activities: | ||||||||
Business combinations, net of cash acquired | (88,075 | ) | (12,501 | ) | ||||
Changes in marketable securities | (46,853 | ) | (2,948 | ) | ||||
Investments in non-marketable equity investments | (1,000 | ) | (265 | ) | ||||
Purchases of property and equipment | (4,054 | ) | (2,423 | ) | ||||
Payments associated with capitalized software development | (3,566 | ) | (2,689 | ) | ||||
Net cash used in investing activities | (143,548 | ) | (20,826 | ) | ||||
Financing activities: | ||||||||
Proceeds from issuance of common stock | 98,014 | -- | ||||||
Borrowings under revolving credit facility | 28,000 | -- | ||||||
Repayments under revolving credit facility | (28,000 | ) | -- | |||||
Proceeds from exercise of stock options | 277 | 462 | ||||||
Taxes paid related to net settlement of equity awards | (748 | ) | (152 | ) | ||||
Payment of earn-outs related to acquisitions | (628 | ) | (261 | ) | ||||
Net cash provided by financing activities | 96,915 | 49 | ||||||
Net (decrease) increase in cash and cash equivalents | (27,502 | ) | 1,325 | |||||
Cash and cash equivalents at beginning of period | 81,995 | 59,537 | ||||||
Cash and cash equivalents at end of period | $ | 54,493 | $ | 60,862 | ||||
Reconciliation of GAAP to Non-GAAP Financial Measures(1) |
||||||||||||||||
(In thousands, except per share data) | ||||||||||||||||
Unaudited | ||||||||||||||||
Three Months Ended
|
Six Months Ended
|
|||||||||||||||
2015 |
2014 |
2015 |
2014 |
|||||||||||||
GAAP net income | $ | 1,473 | $ | 2,364 | $ | 4,195 | $ | 4,311 | ||||||||
Interest income | (54 | ) | (59 | ) | (109 | ) | (117 | ) | ||||||||
Interest expense | 93 | 13 | 137 | 25 | ||||||||||||
Income tax provision | 1,047 | 1,769 | 3,124 | 3,165 | ||||||||||||
Share-based compensation expense | 1,938 | 450 | 2,347 | 834 | ||||||||||||
Depreciation and amortization | 4,256 | 2,722 | 7,509 | 5,123 | ||||||||||||
Adjusted EBITDA | $ | 8,753 | $ | 7,259 | $ | 17,203 | $ | 13,341 | ||||||||
GAAP revenues | $ | 52,145 | $ | 42,476 | $ | 99,301 | $ | 80,825 | ||||||||
Add: deferred revenue write-down | 2,663 | 703 | 3,241 | 1,072 | ||||||||||||
Non-GAAP revenues | $ | 54,808 | $ | 43,179 | $ | 102,542 | $ | 81,897 | ||||||||
GAAP operating income | $ | 2,564 | $ | 4,110 | $ | 7,354 | $ | 7,408 | ||||||||
Add: deferred revenue write-down | 2,663 | 703 | 3,241 | 1,072 | ||||||||||||
Non-GAAP operating income | $ | 5,227 | $ | 4,813 | $ | 10,595 | $ | 8,480 | ||||||||
GAAP net income | $ | 1,473 | $ | 2,364 | $ | 4,195 | $ | 4,311 | ||||||||
Add: deferred revenue write-down, net of tax | 1,555 | 402 | 1,857 | 619 | ||||||||||||
Non-GAAP net income | $ | 3,028 | $ | 2,766 | $ | 6,052 | $ | 4,930 | ||||||||
(1) This press release contains certain non-GAAP financial measures, including non-GAAP net income, non-GAAP operating income, non-GAAP revenue, and adjusted EBITDA, which are used by management in analyzing its financial results and ongoing operational performance. |
||||||||||||||||
This press release includes certain forward-looking statements
(statements other than solely with respect to historical fact),
including statements regarding expectations for the financial
performance for 2015 that involve risks and uncertainties regarding
View source version on businesswire.com: http://www.businesswire.com/news/home/20150720006310/en/
Chief
Financial Officer
ir@healthstream.com
or
Media:
Vice President, Investor Relations
mollie.condra@healthstream.com
Source:
News Provided by Acquire Media